Skip to the page

Data / Drug companies / Guangzhou Yanxi Biotechnology Co., Ltd

Guangzhou Yanxi Biotechnology Co., Ltd: 10 products in the FDA NDC directory, labeler code 84025

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Guangzhou Yanxi Biotechnology Co., Ltd (labeler code 84025) lists 10 products in the FDA National Drug Code Directory, covering 5 finished drugs by generic name. By type: 10 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 13, 2026.

The request: Watch Guangzhou Yanxi Biotechnology Co., Ltd (FDA labeler code 84025): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
84025
Products in commercial distribution
10
Packages
10
Finished drugs by generic name
5
Prescription products
0
Over the counter products
10
Started marketing in the last 12 months
10
Earliest marketing start
September 18, 2026
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs10100%

Products by type

TypeProductsShare
Over the counter drugs10100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
5% minoxidil37
5% minoxidil hair growth21
Minoxidil hair regrowth roll-on21
5% minoxidil for men and women11
Minoxidil hair growth oil11

Dosage forms

Dosage formProductsShare
Spray770%
Solution220%
Oil110%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
5% Minoxidil84025-337SprayOver the counter monograph drugsOctober 13, 2026
5% Minoxidil84025-335SprayOver the counter monograph drugsOctober 10, 2026
5% Minoxidil Hair Growth84025-334SprayOver the counter monograph drugsSeptember 28, 2026
5% Minoxidil Hair Growth84025-333SprayOver the counter monograph drugsSeptember 28, 2026
5% Minoxidil for Men and Women84025-332SprayOver the counter monograph drugsSeptember 20, 2026
Minoxidil Hair Regrowth Roll-On84025-331SolutionOver the counter monograph drugsSeptember 20, 2026
Minoxidil Hair Regrowth Roll-On84025-330SolutionOver the counter monograph drugsSeptember 20, 2026
5% Minoxidil84025-329SprayOver the counter monograph drugsSeptember 20, 2026
5% Minoxidil84025-328SprayOver the counter monograph drugsSeptember 20, 2026
Minoxidil Hair Growth Oil84025-327OilOver the counter monograph drugsSeptember 18, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.